Sigma Healthcare Limited
Symbole: SIG.AX
ASX
1.295
AUDPrix du marché aujourd'hui
447.5904
Ratio P/E
3.5707
Ratio PEG
1.95B
Cap MRK
- 0.01%
Rendement DIV
Sigma Healthcare Limited (SIG-AX) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 356.5 | 16.6 | 31.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 320 | 337.4 | 358.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 221.1 | 324.9 | 321.6 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 14.9 | 6.9 | 50.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 912.5 | 685.8 | 761.6 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 271.8 | 290.9 | 281.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 89.1 | 95.2 | 103 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 20 | 118.2 | 128.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 109.1 | 213.5 | 231 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 88.3 | 89.2 | 85.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | -95.2 | -103 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 491.6 | 515.8 | 513.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 303.4 | 406 | 352.3 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 9.8 | 12.9 | 25.7 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 126.8 | 80 | 165 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 58 | 57.4 | 77.8 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 160.2 | 246.5 | 329 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 126.8 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 531.5 | 723.8 | 786.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1682.4 | 1286.1 | 1286.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -769.2 | -761.6 | -741.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2.9 | 3 | 2.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -45.3 | -51.7 | -60.7 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 870.8 | 475.9 | 487.2 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 1.8 | 1.8 | 1.6 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 872.6 | 477.8 | 488.8 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.6 | 227 | 323.4 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -219.9 | 210.3 | 292.3 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4.5 | 1.8 | -7.2 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | 15.2 | -65.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 1.9 | 0 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 16.3 | 87.2 | -76.1 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 10.9 | 27.5 | -30.7 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 103.7 | -3.2 | 27.5 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -102.7 | 53.5 | -7.1 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 4.3 | 9.3 | -65.8 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -7.2 | 6.3 | 75.1 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 8.9 | 0.5 | 0 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -10.5 | -0.8 | -2.4 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1.5 | 0.3 | 0 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 10.5 | 0.8 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 5.7 | -28.6 | -16.6 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -80 | -85 | -165 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 396.1 | 0.9 | 0.2 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -9.5 | -16.9 | -165.2 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -10.8 | -15 | -19.9 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.8 | -1 | 478.8 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 295.8 | -116.9 | 128.9 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 339.8 | -14.5 | 15 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 356.5 | 16.6 | 31.1 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 16.6 | 31.1 | 16.1 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 42 | 142.7 | -46.3 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 37.2 | 113.3 | -60.5 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3322.1 | 3660.2 | 3446.2 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3132.2 | 3436.2 | 3246.7 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 189.8 | 224.1 | 199.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 261.8 | 293 | 309.6 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3394 | 3729.2 | 3556.3 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.7 | 0.6 | 0.2 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -71.9 | -68.9 | -110.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 8.6 | 5.5 | -8.3 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.3 | 2.4 | -2 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 4.5 | 1.8 | -7.2 |
Questions fréquemment posées
Quel est le total de Sigma Healthcare Limited (SIG.AX) de l'actif total?
Sigma Healthcare Limited (SIG.AX) Le total des actifs est 1404133000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.057.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.024.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.001.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.022.
Qu'est-ce que Sigma Healthcare Limited (SIG.AX) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 4509000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 136631000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 261767000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.